Full Press Release Details
Nurix is writing medicine’s next chapter using targeted protein degradation as a new script to outmatch disease.
More About Nurix
Nurix is writing medicine’s next chapter using targeted protein degradation as a new script to outmatch disease.
More About Nurix
Nurix is writing medicine’s next chapter using targeted protein degradation as a new script to outmatch disease.
More About Nurix
OUR SCIENCE
Targeted protein degradation
• Degraders
• Degrader Antibody Conjugates (DACs)
• The DEL-AI Advantage
• Our Pipeline
Our degraders are designed to eliminate disease-causing proteins by harnessing the cell’s natural protein degradation machinery.
More On Degraders
Our DACs combine the cell specificity of antibodies with the potency, selectivity, and catalytic activity of degraders, delivering innovative medicines with the potential for enhanced precision and improved safety.
More On DACs
Our innovative and prolific DEL-AI drug discovery engine is powering the protein degradation revolution.
Explore Our Technology
We are translating the science of degradation into clinical progress, advancing a multi-modal pipeline that targets a broad range of diseases in oncology, immunology, and neurology.
See Our Pipeline
OUR MISSION
Establishing degrader-based medicines at the forefront of patient care
We are steadfast in our pursuit to provide patients with safer, deeper, more durable responses for sustained disease control.
See Our Clinical Trials
OUR CULTURE
Surpass what is possible
We believe in the transformative power of targeted protein degradation to unlock a new universe of treatment options for patients. Join us in writing medicine’s next chapter.
Search Career Opportunities
OUR FOCUS
The latest at Nurix
See All News